IBM Has Fallen 16% as Anthropic Puts Them In The Bullseye

Core Viewpoint - IBM's stock has fallen 16% year-to-date due to concerns over Anthropic's Claude Code tool, which threatens to automate COBOL modernization, a key revenue stream for IBM's consulting business [1][2] Group 1: Stock Performance and Market Reaction - IBM's stock dropped 15.9% year-to-date, with a significant decline of nearly 13% in a single session following Anthropic's announcement [1] - Social sentiment around IBM fluctuated dramatically, with scores dropping from 88 (very bullish) to 32 (bearish) within 48 hours after the announcement [1] - Institutional investors like Franklin Resources and Invesco have shown confidence by increasing their stakes in IBM despite the stock's decline [1][2] Group 2: Financial Performance - IBM reported Q4 revenue of $19.69 billion, a 12% increase year-over-year, and generative AI bookings exceeded $12.5 billion [1] - The consulting segment, which accounts for approximately one-third of IBM's revenue, contracted by 2% in Q4 and continued to decline in Q1 2025 [1] - Full-year free cash flow reached $12.7 billion, the highest in over a decade, indicating strong fundamentals despite recent challenges [1] Group 3: Competitive Landscape and Risks - Anthropic's Claude Code tool directly targets IBM's COBOL modernization work, raising concerns about the sustainability of IBM's consulting revenue [1] - IBM's total debt stands at $55 billion, down $1.6 billion year-over-year, which may limit its flexibility to adapt to competitive pressures [1] - Analysts have set an average price target of $318 for IBM, compared to its current price around $247, suggesting potential upside if the company can navigate these challenges [2]